13D Filing: Bain Capital Life Sciences Fund, L.P. and Dicerna Pharmaceuticals Inc (DRNA)

previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240....

Keep Reading →